MetaCap

CG Oncology (CGON) News

NASDAQ: CGONHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

79.47-2.43 (-2.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CGON news summary

We found 12 recent headlines mentioning CG Oncology (CGON): 6 in the past week and 10 in the past 30 days, most often from Nasdaq, Seeking Alpha, Investing.com. For price context, CGON is down 2.97% at $79.47. The most recent story, "CG Oncology, Inc. Announces Topline Data for Phase 3 PIVOT-006 Trial", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest CG Oncology headlines

Stocks mentioned alongside CGON

Compare CGON